Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion-transmitted Chagas' disease

S Wendel

    Current Opinion in Hematology
    |November 14, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Transfusion-transmitted Chagas' disease, caused by Trypanosoma cruzi, is a growing concern outside Latin America due to migration. Asymptomatic infected donors complicate screening, necessitating improved blood safety measures.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Who Can You Trust? Assessing Vulnerability to Digital Imposter Scams.

    Journal of consumer policy·2023
    Same author

    Short-term effects of stored homologous red blood cell transfusion on cardiorespiratory function and inflammation: an experimental study in a hypovolemia model.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2017
    Same author

    International society of blood transfusion working party on red cell immunogenetics and terminology: report of the Seoul and London meetings.

    ISBT science series·2017
    Same author

    Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5.

    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
    Same author

    Prevention of transfusion-transmitted cytomegalovirus (CMV) infection: Standards of care.

    Vox sanguinis·2014
    Same author

    International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012).

    Vox sanguinis·2013
    Same journal

    Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

    Current opinion in hematology·2026
    Same journal

    Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

    Current opinion in hematology·2026
    Same journal

    Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

    Current opinion in hematology·2026
    Same journal

    From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

    Current opinion in hematology·2026
    Same journal

    Bidirectional relationship between metabolic and thrombotic disease mechanisms.

    Current opinion in hematology·2026
    Same journal

    The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

    Current opinion in hematology·2026
    See all related articles

    Area of Science:

    • Infectious Diseases
    • Hematology
    • Public Health

    Background:

    • Transfusion-transmitted Chagas' disease (TTCD) has been known since 1952.
    • Historically confined to Latin America, TTCD cases now emerge in North America due to increased emigration.
    • Trypanosoma cruzi-infected blood donors are typically asymptomatic, posing a challenge for screening.

    Purpose of the Study:

    • To review the epidemiology of TTCD.
    • To discuss the risks, clinical manifestations, and prevention of TTCD.
    • To highlight the importance of blood donor screening for Trypanosoma cruzi.

    Main Methods:

    • This is a review article.
    • It synthesizes information on TTCD epidemiology, clinical aspects, and prevention strategies.

    Related Experiment Videos

  • Focuses on blood donor screening protocols.

    • Main Results:

    • Emigration has expanded the geographic reach of TTCD to North America.
    • Asymptomatic infected donors are a significant challenge for blood safety.
    • Lack of familiarity with risk factors among blood bank personnel can hinder detection.

    Conclusions:

    • Preventing TTCD requires enhanced vigilance and screening protocols for blood donors.
    • Understanding the epidemiology and clinical presentation is crucial for effective prevention.
    • Improved blood bank awareness and targeted screening are essential to mitigate TTCD risks.